News

Article

Prevent Blindness seeks to bring awareness to eye inflammation with Inflammatory Eye Disease (IED) Awareness Week

The week of September 18-24 will be dedicated to educating the public on IEDs such as uveitis, keratitis, conjunctivitis and more.

(Image Credit: AdobeStock/Audrius Merfeldas)

(Image Credit: AdobeStock/Audrius Merfeldas)

Prevent Blindness has declared the week of September 18 through September 24 as Inflammatory Eye Disease (IED) Awareness Week.

In a press release from Prevent Blindness, the company stated this third annual declaration aims to “educate the public on ways to protect vision and prevent unnecessary vision loss.”1

Uveitis, keratits, conjunctivitis, rheumatoid arthritis, and thyroid eye disease are all forms of IEDs. In addition to downloadable fact sheets, Prevent Blindness is also hosting a dedicated webpage for education on IEDs.

Jeff Todd, president and CEO of Prevent Blindness, and Steven Yeh, MD, Professor and Stanley Truhlsen Jr Chair of Ophthalmology, Truhlsen Eye Institute, University of Nebraska Medical Center sat down to have a discussion about uveitis and other IEDs.

“Although ‘Inflammatory Eye Disease’ may not be a term that most people are familiar with, it is a condition that can have severe impact on vision if left untreated,” said Todd. “We encourage people to educate themselves on the various types of IEDs and whether they are at risk for, or have developed them already, to help prevent unnecessary vision loss.”

The company stressed that since IEDs can cause permanent damage to the eyes and vision loss that cannot be reversed, anyone who notices any signs or symptoms of an IED should make an appointment to see a professional eye doctor immediately.

References:

  1. Prevent Blindness Offers Information on Inflammatory Eye Diseases, Including a New Video, Fact Sheets and Social Media Graphics, to Educate Public on Ways to Protect Vision and Prevent Unnecessary Vision Loss. Press Release. Released September 15, 2023. Accessed September 18, 2023. https://preventblindness.org/2023-inflammatory-eye-disease-week/

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.